These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients. Widanapathirana L; Tale S; Reineke TM Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484 [TBL] [Abstract][Full Text] [Related]
3. Crystal Structure Analysis of the First Discovered Stability-Enhanced Solid State of Tenofovir Disoproxil Free Base Using Single Crystal X-ray Diffraction. An JH; Kiyonga AN; Yoon W; Ryu HC; Kim JS; Kang C; Park M; Yun H; Jung K Molecules; 2017 Jul; 22(7):. PubMed ID: 28708115 [TBL] [Abstract][Full Text] [Related]
4. Investigation of excipient and processing on solid phase transformation and dissolution of ciprofloxacin. Li X; Zhi F; Hu Y Int J Pharm; 2007 Jan; 328(2):177-82. PubMed ID: 16978809 [TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method. Douroumis D; Bouropoulos N; Fahr A J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229 [TBL] [Abstract][Full Text] [Related]
6. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408 [TBL] [Abstract][Full Text] [Related]
7. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714 [TBL] [Abstract][Full Text] [Related]
8. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method. Kushida I; Gotoda M Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663 [TBL] [Abstract][Full Text] [Related]
9. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization, and Crystal Chemistry of Tasimelteon, a Melatonin Agonist, in Its Anhydrous and Hemihydrate Forms. Ventimiglia G; Bellomi S; Barreca G; Giovannelli L; Masciocchi N J Pharm Sci; 2018 Feb; 107(2):543-549. PubMed ID: 28947337 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of emulsified solid dispersions containing docetaxel. Chen Y; Shi Q; Chen Z; Zheng J; Xu H; Li J; Liu H Arch Pharm Res; 2011 Nov; 34(11):1909-17. PubMed ID: 22139690 [TBL] [Abstract][Full Text] [Related]
13. Update on compatibility assessment of empagliflozin with the selected pharmaceutical excipients employed in solid dosage forms by thermal, spectroscopic and chromatographic techniques. Niguram P; Polaka SN; Rathod R; Kalia K; Kate AS Drug Dev Ind Pharm; 2020 Feb; 46(2):209-218. PubMed ID: 31933394 [TBL] [Abstract][Full Text] [Related]
14. Salt formation improved the properties of a candidate drug during early formulation development. Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322 [TBL] [Abstract][Full Text] [Related]
15. Crystal growth formation in melt extrudates. Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578 [TBL] [Abstract][Full Text] [Related]
16. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Vogt M; Kunath K; Dressman JB Eur J Pharm Biopharm; 2008 Feb; 68(2):330-7. PubMed ID: 17574401 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media. Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638 [TBL] [Abstract][Full Text] [Related]